Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxidative stress in bisphosphonate-related osteonecrosis of the jaws.

Bagan J., Sáez GT., Tormos MC., Gavalda-Esteve C., Bagan L., Leopoldo-Rodado M., Calvo J., Camps C.

ObjectivesTo analyze whether oxidative stress (OS) changes are present in patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ) versus controls.Materials and methodsOxidative stress was analyzed in serum and unstimulated saliva of three groups: Group 1 consisted of 24 patients who had been treated with intravenous bisphosphonates (ivBPs) and developed BRONJ, group 2 consisted of 20 patients who had received ivBPs and did not develop BRONJ, and group 3 comprised 17 control subjects. Reduced glutathione (GSH), malondialdehyde (MDA), oxidized glutathione (GSSG), and 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxo-dG) levels, as well as the GSSG/GSH ratio, were measured.ResultsMean serum and saliva levels of MDA, GSSG, and 8-oxo-dG and the GSSG/GSH ratio were significantly higher in patients with BRONJ than in controls. We found no significant difference in OS according to BRONJ stage, sex, or location in the jaws. Logistic regression analysis revealed that the GSSG/GSH ratio was a significant factor predicting the development of BRONJ (P = 0.01).ConclusionsOxidative stress was detected in patients with BRONJ, and the GSSG/GSH ratio was the most significant OS variable found; it was a significant factor predicting the development of BRONJ.

More information Original publication

DOI

10.1111/jop.12151

Type

Journal article

Publication Date

2014-05-01T00:00:00+00:00

Volume

43

Pages

371 - 377

Total pages

6

Addresses

D, e, p, a, r, t, m, e, n, t, , o, f, , O, r, a, l, , M, e, d, i, c, i, n, e, ,, , V, a, l, e, n, c, i, a, , U, n, i, v, e, r, s, i, t, y, ,, , V, a, l, e, n, c, i, a, ,, , S, p, a, i, n, ;, , S, e, r, v, i, c, e, , o, f, , S, t, o, m, a, t, o, l, o, g, y, , a, n, d, , M, a, x, i, l, l, o, f, a, c, i, a, l, , S, u, r, g, e, r, y, ,, , U, n, i, v, e, r, s, i, t, y, , G, e, n, e, r, a, l, , H, o, s, p, i, t, a, l, ,, , V, a, l, e, n, c, i, a, ,, , S, p, a, i, n, .

Keywords

Saliva, Humans, Multiple Myeloma, Breast Neoplasms, Malondialdehyde, Diphosphonates, Adrenal Cortex Hormones, Glutathione, Glutathione Disulfide, Deoxyguanosine, Antineoplastic Agents, Dental Plaque Index, DMF Index, Oral Hygiene Index, Case-Control Studies, Sex Factors, Oxidative Stress, Aged, Middle Aged, Female, Male, Bisphosphonate-Associated Osteonecrosis of the Jaw, Administration, Intravenous, Biomarkers, 8-Hydroxy-2'-Deoxyguanosine